Fatal anaphylaxis following jack jumper ant sting in southern Tasmania - PubMed (original) (raw)
Case Reports
Fatal anaphylaxis following jack jumper ant sting in southern Tasmania
S G Brown et al. Med J Aust. 2001 Dec.
Abstract
The "jack jumper" ant (Myrmecia pilosula) is a major cause of anaphylaxis in Tasmania. We describe four deaths attributed to stings by this ant between 1980 and 1999. All victims were men aged 40 years or over with significant comorbidities; two were taking angiotensin-converting enzyme inhibitors, which may increase risk of severe anaphylaxis. Three victims had known ant-sting allergy, but only one carried adrenaline, which he did not use. Another believed he was protected by previous attempts at hyposensitisation with whole ant-body extract. There is potential to prevent deaths by careful education of people with known allergy, prescribing of adrenaline for auto-injection and development of an effective hyposensitisation therapy.
Similar articles
- Prevalence, severity, and natural history of jack jumper ant venom allergy in Tasmania.
Brown SG, Franks RW, Baldo BA, Heddle RJ. Brown SG, et al. J Allergy Clin Immunol. 2003 Jan;111(1):187-92. doi: 10.1067/mai.2003.48. J Allergy Clin Immunol. 2003. PMID: 12532117 - Causes of ant sting anaphylaxis in Australia: the Australian Ant Venom Allergy Study.
Brown SG, van Eeden P, Wiese MD, Mullins RJ, Solley GO, Puy R, Taylor RW, Heddle RJ. Brown SG, et al. Med J Aust. 2011 Jul 18;195(2):69-73. doi: 10.5694/j.1326-5377.2011.tb03209.x. Med J Aust. 2011. PMID: 21770873 - Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial.
Brown SG, Wiese MD, Blackman KE, Heddle RJ. Brown SG, et al. Lancet. 2003 Mar 22;361(9362):1001-6. doi: 10.1016/S0140-6736(03)12827-9. Lancet. 2003. PMID: 12660058 Clinical Trial. - Prevention of anaphylaxis with ant venom immunotherapy.
Brown SG, Heddle RJ. Brown SG, et al. Curr Opin Allergy Clin Immunol. 2003 Dec;3(6):511-6. doi: 10.1097/00130832-200312000-00014. Curr Opin Allergy Clin Immunol. 2003. PMID: 14612677 Review. - Ant allergy in Asia and Australia.
Shek LP, Ngiam NS, Lee BW. Shek LP, et al. Curr Opin Allergy Clin Immunol. 2004 Aug;4(4):325-8. doi: 10.1097/01.all.0000136761.51195.01. Curr Opin Allergy Clin Immunol. 2004. PMID: 15238800 Review.
Cited by
- Global View on Ant Venom Allergy: from Allergenic Components to Clinical Management.
Wanandy T, Mulcahy E, Lau WY, Brown SGA, Wiese MD. Wanandy T, et al. Clin Rev Allergy Immunol. 2022 Feb;62(1):123-144. doi: 10.1007/s12016-021-08858-1. Epub 2021 Jun 1. Clin Rev Allergy Immunol. 2022. PMID: 34075569 Review. - Structure-based epitope prediction and assessment of cross-reactivity of Myrmecia pilosula venom-specific IgE and recombinant Sol g proteins (Solenopsis geminata).
Buraphaka H, Dobutr T, Wiese MD, Lopata AL, Daduang S. Buraphaka H, et al. Sci Rep. 2024 May 15;14(1):11145. doi: 10.1038/s41598-024-61843-4. Sci Rep. 2024. PMID: 38750087 Free PMC article. - Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation.
Brown SG, Blackman KE, Stenlake V, Heddle RJ. Brown SG, et al. Emerg Med J. 2004 Mar;21(2):149-54. doi: 10.1136/emj.2003.009449. Emerg Med J. 2004. PMID: 14988337 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials